AGC Bio secures lentiviral contract; Thermo Fisher to make Cybin assetnews2025-05-15T13:46:41+00:00May 15th, 2025|Endpoints News|
Merck KGaA Q1 earnings: Tariff surcharge for US customers will continuenews2025-05-15T11:03:52+00:00May 15th, 2025|Endpoints News|
Sanofi touts $20B investment in US over five yearsnews2025-05-14T19:28:38+00:00May 14th, 2025|Endpoints News|
Some generics, biosimilar drugmakers say they can withstand tariff impactnews2025-05-13T15:27:00+00:00May 13th, 2025|Endpoints News|
Roche could rethink $50B US expansion plan if new policies ‘harm’ operationsnews2025-05-12T17:09:47+00:00May 12th, 2025|Endpoints News|
Iovance stock plummets after lowered full-year guidancenews2025-05-09T18:31:52+00:00May 9th, 2025|Endpoints News|
Lonza says its US-based sites are in high demand as pharma tariffs nearnews2025-05-09T14:17:22+00:00May 9th, 2025|Endpoints News|
Bristol Myers’ $40B US investment; Shionogi to buy Japanese drugmakernews2025-05-08T15:22:32+00:00May 8th, 2025|Endpoints News|
Gilead reveals plans to put another $11B into US manufacturingnews2025-05-07T19:38:02+00:00May 7th, 2025|Endpoints News|
Teva plans staff cuts as it commits to accelerating growthnews2025-05-07T19:30:41+00:00May 7th, 2025|Endpoints News|
